What is the main business of Polskie Centrum Badań I Rozwoju?

The main business activity of Polskie Centrum Badań I Rozwoju focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 5, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Juliusza Słowackiego 55, 60-521 Poznań.

Who is on the management board?

The management board consists of: Cezary Piotr Ziarkowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of $927 in 2025, which is an increase of 50.0% compared to 2024.

No, the company recorded a net loss of $839 in 2025. For comparison, in 2024 the loss was $946, meaning the company reduced its loss by 11.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $603 in 2025, representing 100% of all operating expenses.

Polskie Centrum Badań I Rozwojusp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-08-05

Share capital

5 000,00 PLN

Registered address

ul. Juliusza Słowackiego 55/1, 60-521 Poznań, Poland

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 926.67MedianUSD 38.31kAverageUSD 2.31m

Net profit

This companyUSD -839.25MedianUSD -1.50kAverageUSD -84.98k

Operating costs

This companyUSD 602.71MedianUSD 56.25kAverageUSD 2.29m

Assets

This companyUSD 3.22kMedianUSD 116.77kAverageUSD 2.72m

Industry

Bank accounts

Registered as a VAT taxpayer on 2015-08-07. Active

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Cezary Piotr Ziarkowski — President of the Management Board

Manner of representation

If the management board consists of one member, that member is authorised to represent the company independently. If the management board consists of more than one member, the company is represented by each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Medcamp S.A.	100	$1,350.62	100%

Beneficial owners

Person	Rights
January Roman Ciszewski (55)	Osoba (wraz ze spółką której jest prezesem) posiada 29,44 % akcji w spółce będącej 100 % wspólnikiem zgłaszanej spółki

Competitors

Name	Revenue	Website
GenxoneS.A.	$665,361.35	genxone.eu
Polbiotech Laboratoriumsp. z o.o.	$645,943.81	polbiotech.pl
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
Xenstatssp. z o.o.	$66,774.27	xenstats.com
Dairy Biotechnologiessp. z o.o.	$1,485.09	milcu.eu
Medical Algorithmssp. z o.o.	$682.08	medicalalgorithms.eu
Fungotechsp. z o.o.	$187.68	fungo.tech
Dystrogen TherapeuticsS.A.	—	dystrogen.com
MIMO BiotechP.S.A.	—	mimobiotech.com

Change history

Date	Event
2022-01-01	Business resumed
2019-12-31	Business suspended
2019-10-04	Address change (Ul. Jasielska 16a, 60-476, Poznań → Ul. Juliusza Słowackiego 55/1, 60-521, Poznań)
2016-07-01	Name change (Estel Corporation → Polskie Centrum Badań I Rozwoju)
2016-05-04	Address change (Ul. Ksawerego Zakrzewskiego 11e, 61-693, Poznań → Ul. Jasielska 16a, 60-476, Poznań)

FAQ

Last updated: 2026-07-27